Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

TLV:REKA Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	133	151	169	176	266	306
Market Cap Growth	-18.07%	-10.35%	-3.96%	-33.89%	-13.13%	34.20%
Enterprise Value	262	295	338	321	420	441
Last Close Price	11.61	13.25	14.78	15.39	22.40	25.79
PE Ratio	-	24.37	-	-	40.12	28.33
PS Ratio	0.44	0.47	0.52	0.60	1.01	1.15
PB Ratio	0.88	0.93	1.08	1.08	1.54	1.85
P/TBV Ratio	1.42	1.50	1.90	1.39	1.90	1.90
P/FCF Ratio	9.07	8.47	10.01	5.48	34.59	-
P/OCF Ratio	6.31	5.70	5.95	4.50	12.55	27.11
EV/Sales Ratio	0.87	0.92	1.05	1.10	1.59	1.66
EV/EBITDA Ratio	91.01	17.05	13.00	7.87	11.73	10.86
EV/EBIT Ratio	-	-	116.43	24.20	32.49	21.10
EV/FCF Ratio	17.94	16.53	20.07	10.00	54.61	-
Debt / Equity Ratio	0.90	0.83	1.18	1.02	0.96	1.00
Debt / EBITDA Ratio	45.88	5.33	5.61	4.07	4.64	4.10
Debt / FCF Ratio	9.28	7.52	10.89	5.17	21.59	-
Asset Turnover	0.69	0.69	0.69	0.66	0.62	0.68
Inventory Turnover	2.48	2.79	2.56	2.35	2.12	2.36
Quick Ratio	0.90	0.90	1.01	1.06	1.30	1.17
Current Ratio	1.65	1.45	1.75	1.75	2.25	2.10
Return on Equity (ROE)	-8.96%	3.91%	-4.35%	-1.22%	3.91%	6.73%
Return on Assets (ROA)	-4.04%	-0.98%	0.39%	1.87%	1.88%	3.32%
Return on Capital (ROIC)	-5.88%	-1.44%	0.55%	2.48%	2.41%	4.14%
Return on Capital Employed (ROCE)	-9.80%	-2.50%	0.90%	4.30%	3.80%	6.70%
Earnings Yield	-10.64%	4.10%	-4.10%	-1.16%	2.49%	3.53%
FCF Yield	11.02%	11.80%	9.99%	18.25%	2.89%	-2.40%
Dividend Yield	-	-	-	-	3.87%	-
Buyback Yield / Dilution	-4.25%	-	-	-	-	-
Total Shareholder Return	-4.25%	-	-	-	3.87%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.